Boai NKY Medical Holdings Ltd. (SHE:300109)

China flag China · Delayed Price · Currency is CNY
19.03
-0.07 (-0.37%)
Mar 9, 2026, 3:04 PM CST
14.43%
Market Cap 9.25B
Revenue (ttm) 1.45B
Net Income (ttm) 239.53M
Shares Out 486.05M
EPS (ttm) 0.48
PE Ratio 39.28
Forward PE n/a
Dividend 0.25 (1.31%)
Ex-Dividend Date Jul 10, 2025
Volume 19,822,403
Average Volume 14,239,014
Open 19.13
Previous Close 19.10
Day's Range 18.50 - 19.89
52-Week Range 12.75 - 21.11
Beta 0.02
RSI 49.36
Earnings Date Apr 24, 2026

About Boai NKY Medical Holdings

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, oral care, and household care; alcohol, soft drinks, and food; battery, petroleum and natural gas, and photovoltaic; and membrane, textile and dyeing, ag... [Read more]

Sector Materials
Founded 1987
Employees 1,163
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300109
Full Company Profile

Financial Performance

In 2024, Boai NKY Medical Holdings's revenue was 1.61 billion, an increase of 1.45% compared to the previous year's 1.58 billion. Earnings were 349.68 million, a decrease of -29.07%.

Financial Statements

News

There is no news available yet.